Article Text

other Versions

PDF
Incidence and risk factors of early thromboembolic events after mechanical heart valve replacement in patients treated with intravenous unfractionated heparin
  1. Nicolas Allou
  1. Hôpital Bichat, France
    1. Pascale Piednoir
    1. Hôpital Bichat, France
      1. Clarisse Berroeta
      1. Hôpital Bichat, France
        1. Sophie Provenchère
        1. Hôpital Bichat, France
          1. Hassan Ibrahim
          1. Hôpital Bichat, France
            1. Gabriel Baron
            1. Hôpital Bichat, France
              1. Philippe Montravers
              1. Hôpital Bichat, France
                1. Bernard Iung
                1. Hôpital Bichat, France
                  1. Ivan Philip (ivan.philip{at}bch.aphp.fr)
                  1. Hôpital Bichat, France
                    1. Nadine Ajzenberg
                    1. Hôpital Bichat, France

                      Abstract

                      Objective: To evaluate incidence and risk factors, including timing and intensity of anticoagulation, of early thromboembolic events (TE) after mechanical heart valve replacement (MHVR) in patients treated by intravenous unfractionated heparin (IVUH).

                      Design: Prospective observational study, conducted between December 2005 and May 2007.

                      Setting: Haemostasis laboratory, surgical intensive care unit and ward in a university hospital.

                      Patients: Three hundred consecutive patients undergoing MHVR. Mitral or double MHVR were performed in 149 patients, and aortic MHVR in 151 patients. Postoperative anticoagulation was achieved with continuous IVUH according to a standardized protocol. The timing of efficient anticoagulation was recorded for each patient.

                      Main outcome measures: The endpoint was the occurrence of any arterial TE from day 1 to day 30. Transesophageal echocardiography was systematically performed after mitral MHVR.

                      Results: Early TE occurred in 22 patients (14.8 %; 95%CI [9-20]) after a mitral or double MHVR and in 2 patients (1.3%; 95%CI [0-3]) after an aortic MHVR (P=0.005). After adjustment for diabetes mellitus (adjusted OR [95% CI]: 3.3 [1.0-10.9], P=0.049), and for a context of predisposing factors (heparin-induced thrombocytopenia or bradycardia requiring definitive pace-maker implantation) (aOR [95%CI]: 12.8 [3.1-53.3], P=0.0005), effective anticoagulation on day 3 was a protective factor (aOR [95%CI]: 0.28 [0.1-0.8], P=0.018) for early TE after mitral MHVR.

                      Conclusions: Despite the use of IVUH, the rate of early TE after mitral MHVR remained elevated. Our results suggest that early effective anticoagulation is required after mitral MHVR, since inappropriate anticoagulation on day 3 was significantly associated with early TE.

                      Statistics from Altmetric.com

                      Request permissions

                      If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

                      Linked Articles